Rohan mentioned dilution at the product level vs at the corporate level. Going into partnership with an indication is obviously the preferred route leaving maximum upside for future discovery.
We may wonder about future appointments, especially in respect to AI support. I think an AI mania in biotechnology is yet to unfold, and alot of value is yet to be realised imo.
Rohan mentioned dilution at the product level vs at the...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $816.5M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 17.0¢ | $224.4K | 1.287M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29999 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 772055 | 7 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |